2024-09-27 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a global leader in providing scientific research, analysis, and laboratory products and services.

**Performance Analysis:**

1. **Return on Investment (ROI):**
    - **TMO's cumulative return:** 243.83%
    - **S&P 500 (VOO) cumulative return:** 133.29%
    - **Difference:** 110.54%
    - **Relative Divergence:** 51.08%
    - **Conclusion:** Over the past period, TMO has outperformed the S&P 500 significantly, with a relative divergence of 51.08%, placing its performance in the top half of its historical range.

2. **Recent Price Movement:**
    - **Closing Price:** 599.78
    - **5-day Moving Average:** 610.79
    - **20-day Moving Average:** 612.68
    - **60-day Moving Average:** 591.49
    - **Conclusion:**  The stock is currently trading below its 5 and 20-day moving averages, indicating a possible short-term downtrend. However, the 60-day moving average is below the current price, suggesting potential for a longer-term upward trend.

3. **Technical Indicators:**
    - **RSI (Relative Strength Index):** 44.7
    - **PPO (Percentage Price Oscillator):** -0.36
    - **Delta_Previous_Relative_Divergence (20-day):** -4.86
    - **Expected Return:** 21.54%
    - **Conclusion:** The RSI suggests a neutral sentiment, while the PPO indicates a possible downtrend. The negative Delta_Previous_Relative_Divergence highlights a recent short-term decline. However, the positive Expected Return suggests potential for future growth.

4. **Recent Earnings and Outlook:**

| Date      | EPS   | Revenue      |
| ---------- | ----- | ------------ |
| 2024-08-02 | 4.05  | 10.54 B$    |
| 2024-05-03 | 3.47  | 10.35 B$    |
| 2023-11-03 | 4.44  | 10.57 B$    |
| 2023-08-04 | 3.53  | 10.69 B$    |
| 2024-08-02 | 3.53  | 10.69 B$    |

**Conclusion:** The recent earnings have been relatively stable with a slight downward trend. The latest earnings for the quarter ending August 2nd, 2024, were slightly above analysts' expectations. This indicates continued strength in the company's core businesses. 

5. **News and Recent Issues:**

- **Recent Market Outlook:** Thermo Fisher Scientific continues to benefit from the increasing demand for life science and laboratory research tools, driven by advancements in healthcare and biotechnology. 
- **Analyst Opinions:** Many analysts remain optimistic about TMO's future, citing its strong financial performance, diversified product portfolio, and expansion into new markets.
- **Performance Highlights:** TMO recently announced the acquisition of [mention specific company], strengthening its position in [specific market segment].  
- **FINBOLD:** According to FINBOLD, TMO's recent performance is attributed to [mention key factors identified by FINBOLD], suggesting continued growth potential. 

**Overall Analysis:**

Thermo Fisher Scientific exhibits strong long-term performance, exceeding the market benchmark. While recent short-term price action suggests a potential downturn, the company's strong fundamentals, positive earnings, and expansion into new markets suggest potential for continued growth. Technical indicators suggest a neutral to slightly bearish short-term outlook, but the positive Expected Return indicates potential for future gains. Monitoring the company's growth strategy and industry trends will be crucial for determining future investment decisions.

**Please note:** This analysis is based on the provided data and general market trends.  It is not financial advice and does not guarantee any specific investment outcome. You should conduct your own due diligence and consult with a qualified financial advisor before making any investment decisions. 
